Cue Health Stock Revenue
Cue Health fundamentals help investors to digest information that contributes to Cue Health's financial success or failures. It also enables traders to predict the movement of Cue Stock. The fundamental analysis module provides a way to measure Cue Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cue Health stock.
Cue |
Cue Health Company Revenue Analysis
Cue Health's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Cue Health Revenue | 70.94 M |
Most of Cue Health's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cue Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Cue Health reported 70.94 M of revenue. This is 99.07% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 99.25% higher than that of the company.
Cue Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cue Health's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cue Health could also be used in its relative valuation, which is a method of valuing Cue Health by comparing valuation metrics of similar companies.Cue Health is currently under evaluation in revenue category among its peers.
Cue Fundamentals
| Return On Equity | -0.95 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (4.38) % | |||
| Current Valuation | 5.46 M | |||
| Shares Outstanding | 159.09 M | |||
| Shares Owned By Insiders | 11.56 % | |||
| Shares Owned By Institutions | 52.80 % | |||
| Number Of Shares Shorted | 776.46 K | |||
| Price To Earning | 16.86 X | |||
| Price To Book | 0.10 X | |||
| Price To Sales | 0.36 X | |||
| Revenue | 70.94 M | |||
| Gross Profit | (17.95 M) | |||
| EBITDA | (240.44 M) | |||
| Net Income | (373.46 M) | |||
| Cash And Equivalents | 363.12 M | |||
| Cash Per Share | 2.45 X | |||
| Total Debt | 47.94 M | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 2.95 X | |||
| Book Value Per Share | 1.26 X | |||
| Cash Flow From Operations | (137.81 M) | |||
| Short Ratio | 1.60 X | |||
| Earnings Per Share | (2.13) X | |||
| Price To Earnings To Growth | 0.52 X | |||
| Target Price | 0.5 | |||
| Number Of Employees | 726 | |||
| Beta | 1.09 | |||
| Market Capitalization | 6.9 M | |||
| Total Asset | 339.79 M | |||
| Retained Earnings | (591.54 M) | |||
| Working Capital | 66.9 M | |||
| Current Asset | 115.52 M | |||
| Current Liabilities | 51.82 M | |||
| Net Asset | 339.79 M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Cue Stock
If you are still planning to invest in Cue Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cue Health's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |